Clinical trials
Reperfusion Injury trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 7 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 7 |
| Recruiting | 4 |
| Withdrawn | 4 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Children's Hospital | 2 |
| Dompé Farmaceutici S.p.A | 2 |
| Medicure | 2 |
| Stealth BioTherapeutics Inc. | 2 |
| The Cooper Health System | 2 |
| University of Alabama at Birmingham | 2 |
| Vanderbilt University Medical Center | 2 |
| Westat | 2 |
| Abhinav Humar, MD | 1 |
| Alavita Pharmaceuticals Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Reperfusion Injury | 44 |
| Heart Arrest | 5 |
| Ischemia | 5 |
| Acute Kidney Injury | 3 |
| Delayed Graft Function | 3 |
| Heart Defects, Congenital | 2 |
| Hemorrhage | 2 |
| Hyperoxia | 2 |
| Kidney Diseases | 2 |
| Myocardial Infarction | 2 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.